This Study in Healthy People Tests Whether Taking a Low Strength of Empagliflozin, Linagliptin, and Metformin Together in 1 Pill is the Same as Taking Them in Separate Pills
Clinical trial NCT03629054 · COMPLETED
Trial details
- NCT number
- NCT03629054
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-27
- Primary completion
- 2018-11-05
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.